General Information of Drug Transporter (DT)
DT ID DTD0527 Transporter Info
Gene Name SCN4A
Transporter Name Voltage-gated sodium channel alpha Nav1.4
Gene ID
6329
UniProt ID
P35499
Post-Translational Modification of This DT
Overview of SCN4A Modification Sites with Functional and Structural Information
Sequence
MARPSLCTLV PLGPECLRPF TRESLAAIEQ RAVEEEARLQ RNKQMEIEEP ERKPRSDLEA 
GKNLPMIYGD PPPEVIGIPL EDLDPYYSNK KTFIVLNKGK AIFRFSATPA LYLLSPFSVV 
RRGAIKVLIH ALFSMFIMIT ILTNCVFMTM SDPPPWSKNV EYTFTGIYTF ESLIKILARG 
FCVDDFTFLR DPWNWLDFSV IMMAYLTEFV DLGNISALRT FRVLRALKTI TVIPGLKTIV 
GALIQSVKKL SDVMILTVFC LSVFALVGLQ LFMGNLRQKC VRWPPPFNDT NTTWYSNDTW 
YGNDTWYGNE MWYGNDSWYA NDTWNSHASW ATNDTFDWDA YISDEGNFYF LEGSNDALLC 
GNSSDAGHCP EGYECIKTGR NPNYGYTSYD TFSWAFLALF RLMTQDYWEN LFQLTLRAAG 
KTYMIFFVVI IFLGSFYLIN LILAVVAMAY AEQNEATLAE DKEKEEEFQQ MLEKFKKHQE 
ELEKAKAAQA LEGGEADGDP AHGKDCNGSL DTSQGEKGAP RQSSSGDSGI SDAMEELEEA 
HQKCPPWWYK CAHKVLIWNC CAPWLKFKNI IHLIVMDPFV DLGITICIVL NTLFMAMEHY 
PMTEHFDNVL TVGNLVFTGI FTAEMVLKLI AMDPYEYFQQ GWNIFDSIIV TLSLVELGLA 
NVQGLSVLRS FRLLRVFKLA KSWPTLNMLI KIIGNSVGAL GNLTLVLAII VFIFAVVGMQ 
LFGKSYKECV CKIALDCNLP RWHMHDFFHS FLIVFRILCG EWIETMWDCM EVAGQAMCLT 
VFLMVMVIGN LVVLNLFLAL LLSSFSADSL AASDEDGEMN NLQIAIGRIK LGIGFAKAFL 
LGLLHGKILS PKDIMLSLGE ADGAGEAGEA GETAPEDEKK EPPEEDLKKD NHILNHMGLA 
DGPPSSLELD HLNFINNPYL TIQVPIASEE SDLEMPTEEE TDTFSEPEDS KKPPQPLYDG 
NSSVCSTADY KPPEEDPEEQ AEENPEGEQP EECFTEACVQ RWPCLYVDIS QGRGKKWWTL 
RRACFKIVEH NWFETFIVFM ILLSSGALAF EDIYIEQRRV IRTILEYADK VFTYIFIMEM 
LLKWVAYGFK VYFTNAWCWL DFLIVDVSII SLVANWLGYS ELGPIKSLRT LRALRPLRAL 
SRFEGMRVVV NALLGAIPSI MNVLLVCLIF WLIFSIMGVN LFAGKFYYCI NTTTSERFDI 
SEVNNKSECE SLMHTGQVRW LNVKVNYDNV GLGYLSLLQV ATFKGWMDIM YAAVDSREKE 
EQPQYEVNLY MYLYFVIFII FGSFFTLNLF IGVIIDNFNQ QKKKLGGKDI FMTEEQKKYY 
NAMKKLGSKK PQKPIPRPQN KIQGMVYDLV TKQAFDITIM ILICLNMVTM MVETDNQSQL 
KVDILYNINM IFIIIFTGEC VLKMLALRQY YFTVGWNIFD FVVVILSIVG LALSDLIQKY 
FVSPTLFRVI RLARIGRVLR LIRGAKGIRT LLFALMMSLP ALFNIGLLLF LVMFIYSIFG 
MSNFAYVKKE SGIDDMFNFE TFGNSIICLF EITTSAGWDG LLNPILNSGP PDCDPNLENP 
GTSVKGDCGN PSIGICFFCS YIIISFLIVV NMYIAIILEN FNVATEESSE PLGEDDFEMF 
YETWEKFDPD ATQFIAYSRL SDFVDTLQEP LRIAKPNKIK LITLDLPMVP GDKIHCLDIL 
FALTKEVLGD SGEMDALKQT MEEKFMAANP SKVSYEPITT TLKRKHEEVC AIKIQRAYRR 
HLLQRSMKQA SYMYRHSHDG SGDDAPEKEG LLANTMSKMY GHENGNSSSP SPEEKGEAGD 
AGPTMGLMPI SPSDTAWPPA PPPGQTVRPG VKESLV
PTM type
X-Acetylation X-Disulfide bond X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SCN4A [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1318

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SCN4A Lysine 1318 has the potential to affect its expression or activity.

Disulfide bond

  Cystine

        12 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

280

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 280 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

360

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 360 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

369

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 369 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

375

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 375 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

731

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 731 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

737

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 737 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

769

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 769 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

778

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 778 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1189

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 1189 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1209

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 1209 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1553

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 1553 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SCN4A [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1568

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SCN4A Cystine 1568 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 214 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

288

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 288 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

291

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 291 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

297

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 297 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

315

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 315 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

321

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 321 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

333

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 333 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SCN4A [4]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

362

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 362 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SCN4A [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1191

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 1191 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SCN4A [4]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1205

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SCN4A Asparagine 1205 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Slowing the inactivation of sodium channels and reducing peak sodium currents [5]

Role of PTM

Protein Activity Modulation

Modified Residue

Serine

Modified Location

1328

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1328 have been reported to slow the inactivation of sodium channels and reducing peak sodium currents.

  PTM Phenomenon 2

Have the potential to influence SCN4A [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

172

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 172 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SCN4A [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

666

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 666 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SCN4A [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

850

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 850 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SCN4A [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1010

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1010 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SCN4A [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1443

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1443 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SCN4A [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1751

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1751 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SCN4A [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1761

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1761 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SCN4A [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1789

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1789 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SCN4A [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1791

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Serine 1791 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SCN4A [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1063

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Threonine 1063 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SCN4A [8] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1073

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Threonine 1073 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SCN4A [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1445

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Threonine 1445 has the potential to affect its expression or activity.

  Tyrosine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SCN4A [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1006

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1006 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SCN4A [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1067

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1067 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SCN4A [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1074

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1074 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SCN4A [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1319

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1319 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SCN4A [13] , [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1320

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1320 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SCN4A [16]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1715

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1715 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SCN4A [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1754

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1754 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SCN4A [17]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1780

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SCN4A Tyrosine 1780 has the potential to affect its expression or activity.
References
1 Probing Polarity and Heterogeneity of Lipid Droplets in Live Cells Using a Push-Pull Fluorophore. Anal Chem. 2019 Feb 5;91(3):1928-1935.
2 iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: P35499)
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SCN4A_HUMAN)
4 Structure of the human voltage-gated sodium channel Na(v)1.4 in complex with 1. Science. 2018 Oct 19;362(6412):eaau2486.
5 UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: P35499)
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
8 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
9 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
10 Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
11 A site-specific phosphorylation of the focal adhesion kinase controls the formation of spheroid cell clusters. Neurochem Res. 2014 Jul;39(7):1199-205.
12 TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
13 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
14 Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
15 Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res. 2005 May 13;96(9):991-8.
16 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
17 Protein kinase PKN1 represses Wnt/beta-catenin signaling in human melanoma cells. J Biol Chem. 2013 Nov 29;288(48):34658-70.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.